peptide bond formation and the targets for antibiotic action. University of British Columbia Vancouver, British Columbia The MLS group was defined on the basis of crossresistance patterns and certain synergistic and antago-Canada 2 Department of Microbiology and nistic interactions [9], which showed that they act at the peptidyltransferase center (PTC) of the 50S subunit; Infectious Disease University of Calgary binding involves domains II and V of the 23S rRNA, blocking peptide bond formation in subtly different ways Calgary, Alberta Canada [10-12]. Ribosomal proteins also play roles in MLS binding, presumably by influencing rRNA folding and structure [13, 14]. Recent high-resolution X-ray analyses have shown that the macrolide members of this family inter-Summary fere principally with the transit of the newly synthesized polypeptide chain through the peptide exit channel of The macrolide-lincosamide-streptogramin (MLS) antithe ribosome [15, 16]. biotics are an important group of translation inhibitors Clinically, the MLS antibiotics are used primarily for that act on the 50S ribosome. We show that, at subinthe treatment of a variety of Gram-positive infections, hibitory concentrations, members of the MLS group especially methicillin-resistant staphylococci [17]. The modulate specific groups of bacterial promoters, as increasing appearance of MLS-resistant strains has detected by screening a library of promoter-luxCDABE compromised these applications in recent years, and reporter clones of Salmonella enterica serovar Typhias a result many synthetic derivatives of the macrolides murium. The patterns of transcription permit identihave been made [18]. New and improved variants with fication of classes of promoters having differential enhanced stability and pharmacokinetic behavior have responses to antibiotics of related structure and been developed for the treatment of a variety of emergmode-of-action; studies of antibiotic synergy or antaging bacterial infections, including Helicobacter pylori; onism showed that eukaryotic translation inhibitors macrolide antibiotics also have favorable activity in allemay act on the 50S ribosome. The mechanism of tranviating bacterial infections associated with cystic fibroscriptional modulation is not known but may involve sis [19-21]. bacterial stress responses and/or the disturbance and Use of libraries of promoter-lux fusion constructions subsequent compensation of metabolic networks as has shown that most antibiotics demonstrate typical a result of subtle interference with ribosome function. hormetic responses [22]
Introduction At higher concentrations the compounds exhibit their well characterized inhibitory or cidal activities through Antibiotics are naturally occurring organic molecules of target-related responses, with few transcription changes low molecular weight (Ͻ3000 D) that have been isolated [23]. Antibiotics of dissimilar structural classes and by virtue of their ability to inhibit (or kill) living organisms;
modes of action affect different groups of promoters. in most cases they act by binding to specific cellular Thus, inhibitors of specific steps involved in the complex targets [1] . It is estimated that tens of thousands of such process of translation modulate the activity of distinct molecules have been isolated from bacteria, fungi, and sets of promoters, presumably due to their interaction plants since the beginning of the antibiotic era (around with different sites within the ribosome. Our previous 1950); the major source has been the Streptomycetes studies indicated that different classes of inhibitors [2] . A significant number of antibiotics target the bacteof 30S or 50S function might be distinguished in this rial ribosome, and two major classes have been identiway [23]. fied by their ability to bind and interfere with the function Since the promoters affected at sub-MIC depend to of either the 30S or 50S subunits during translation [3] [4] [5] . a large extent on the nature of the antibiotic class being In recent years, genetic analysis, chemical foot-printing, used, it seems likely that in each case only transcripts nuclear magnetic resonance, and X-ray crystallography associated with particular metabolic networks are afhave permitted high-resolution studies of antibioticfected. The MLS antibiotics provide a good test for this ribosome interactions, and specific binding sites have proposition. Since the early work of Vazquez it has been been defined at the level of single nucleotides in 16S known that these structurally different molecules ( Figure  1) act at nearby or overlapping sites on the 50S ribosome, as manifested by synergistic or competitive bind-*Correspondence: jed@interchange.ubc.ca These positive hits were rescreened, and 193 were se-terial mutants, and have subtle differences in mode of action and interaction [4] . We demonstrate that antibi-lected for an additional overnight rescreen, which identified 169 clones giving a consistent response (3-fold acti-otic-induced transcription patterns provide a convenient method to discriminate between members of the vated or repressed). The distribution of upregulated and downregulated clones identified with the different MLS MLS family and related inhibitors, by providing activity "fingerprints" or "signatures" for the peptidyltransferase antibiotics is summarized in Table 1 . and peptide exit tunnel inhibitors. We suggest that the analysis of sub-MIC-induced transcription patterns
Comparison of Transcription Responses could provide the basis for high-throughput screens to among Different Antibiotics identify novel inhibitory compounds with defined modes
To investigate further the changes in transcription patof action. The luxCDABE reporter system is especially terns, luminescence responses from the primary screeneffective for such assays [24, 25], which could be used ing were reanalyzed to compare directly the activities with crude mixtures containing low concentrations of of any two different compounds. These data were obbacterial metabolites, since alterations in lux gene extained by taking the log 10 of the ratio of the values from pression can be detected with very high sensitivity in the control (LB) and experimental (LB plus antibiotic) liquid or on solid culture media.
groups. In those cases where the ratio was greater than zero, the antibiotic-treated group produced stronger luminescence than the control group. When less than Results zero, the antibiotic-treated group had reduced luminescence compared to the control group. The collected Screening the Promoter-lux Reporter Library with MLS Antibiotics values obtained from each antibiotic treatment were then plotted against a reference antibiotic for compari-A 6500 clone library of promoter-lux S. typhimurium constructs [23, 26] was used to monitor transcriptional son purposes. Each data point represents the activities of a single clone in response to two separate antimicro-changes in the bacterial host on exposure to subinhibitory concentrations of different MLS antibiotics. The bials. For example, in Figure 2B , coordinates (1, 0.5) represent clones that are more strongly activated by the transcriptional profile of S. typhimurium in response to a subinhibitory concentration of azithromycin is shown reference azithromycin (on the X-axis) than by pristinamycin (on the Y-axis). Results with different antibiotics in Figure 2A . Each data point represents the response of a single clone from the library. Points above the diagonal were plotted and the relative distributions can serve as response signatures for each drug. Thus, when the indicate upregulated clones, those below are downregulated. transcription profile of azithromycin was plotted against the profile of pristinamycin, most of the points were After the initial screening, a total of 589 clones from the library were found to be at least 3-fold modulated scattered, with subpopulations located in sectors repre- senting higher levels of activation and repression by of unique promoter-dependent responses were identified. When the results comparing other MLS antibiotics azithromycin compared to pristinamycin. Overall, the results show that azithromycin at 0.31 g/ml induces were compiled in the same way, distinct spectra of promoter-modulation activity for each antibiotic became more potent induction or repression of certain promoters than pristinamycin at 1.25 g/ml; however, a number readily apparent ( Figure 2C ). For example, telithromycin, Table 2) 
indicate that promoters for different genes vary in erythromycin-resistant hosts. in their sensitivity to MLS-modulation (with responses ranging from 3ϫ to 100ϫ) and that the MLS compounds modulate different transcripts with significant overlap.

Responses to Other 50S Subunit Inhibitors
In addition to the MLS, there are a number of antibiotics This promoter sequence information did not reveal any patterns of functional metabolic clustering associated with diverse structures with similar modes of action binding to the 50S ribosome to block translation. The 169 with the different antibiotic classes. A significant number of the promoter responses were S. typhimurium genes MLS-active promoter-lux S. typhimurium clones were screened against these antibiotics and representative of unknown function. Thus, discernable antibiotic signatures were identified, but they do not appear to be asso-transcription/modulation results are shown in Table 3 . As expected, considerable differences in promoter re-ciated with any specific biochemical networks, such as the well characterized stress responses. sponses were observed. The resolving power of the luxreporter response effectively discriminates between 50S inhibitors acting at different target sites on the ribosome.
Transcriptional Responses Some promoter-lux constructs had broad-spectrum rein MLS-Resistant Strains sponses (tsr) while others had very limited responses Clinically significant resistance to the MLS antibiotics (ybfE). Two antibiotics acting specifically on the 60S has been known for some time; mutations in the bacteribosome of eukaryotic cells, anisomycin and cyclohexirial chromosome or the acquisition of resistance plasmide, were included in this screening. Anisomycin at a mids/transposons can lead to a number of resistance high concentration (200 g/disc) elicited a weak lumiphenotypes [20]. Cross-resistance between the MLS nescence response with the ptsr-lux construct (with no compounds (the MLS B phenotype) is common, and the effect on growth of the bacteria). On the other hand, early studies of Vazquez and collaborators [28] provided cycloheximide had no detectable activity. However, the first convincing evidence that this class of comboth eukaryotic inhibitors were found to influence tranpounds interacts at overlapping site(s) on the 50S riboscription effects when used in combination with MLS some at the PTC. We tested MLS-resistant strains for antibiotics (see below.) their response to subinhibitory antibiotic concentrations to establish that transcription modulation requires known ribosome binding sites. Studies with macrolide-resistant
Interactions between Inhibitors Acting on the 50S Subunit strains carrying mutant rplV (L5) and rplD (L22) alleles showed that ribosome mutations alter MLS responses
In the mid-1970s David Vazquez and his collaborators studied synergistic or antagonistic interactions between [23]. Here we employed S. typhimurium carrying a plas-various translation inhibitors [28] as determined by measuring competition (or enhancement) of ribosome binding using radio-labeled antibiotics; these results were interpreted in terms of overlapping binding sites on the 50S ribosome. Subsequent work using sensitivity-disc and tube-dilution studies have demonstrated frequent synergistic and antagonistic interactions between antibiotics; a number of these interactions are of clinical significance [30] . The lux-reporter strains provide an exquisitely sensitive method for the detection of interactions between MLS antibiotics and other 50S inhibitors. Some typical experiments are shown in Figure 3 : they reveal a range of interactions between translation inhibitors acting on the 50S ribosome. The mechanisms underlying these interactions are not well defined, and it is not known if any given interaction illustrates overlaps in binding sites, allosteric interactions, or some other biochemical effect. Nonetheless such screening may be of value in mechanism-of-action studies and in indicating potential positive or negative effects in the therapeutic use of antimicrobials.
Anisomycin and cycloheximide are considered to be primarily inhibitors of translation in eukaryotes [31] , although some Archaea are susceptible to anisomycin. Using the more sensitive transcription modulation response, we examined the possibility that the eukaryotic inhibitors might have functional interactions with bacterial inhibitors at the ribosome level. Anisomycin and cycloheximide were found to have concentrationdependent effects on activation induced by macrolide (erythromycin and azithromycin) and ketolide (telithromycin) antibiotics. At high (but noninhibitory) concentrations (100 g/ml), they antagonized the antibacterial compounds, as indicated by reduced luminescence responses (not shown). However at lower concentrations (25 g/ml), anisomycin and cycloheximide markedly enhanced the activation of certain promoter fusions by azithromycin and telithromycin. (Figure 4 ).
Discussion
Screening for the targeted inhibition of biochemical processes in microbes has provided a rich collection of naturally derived antibiotics that have been the foundation of the success of the pharmaceutical industry in the treatment of infectious diseases [32]. Mode-of-action studies began early in the antibiotic era [33] and led to the identification of a variety of specific macromolecular targets in bacterial cells. Increasingly sophisticated molecular studies of antibiotic/ribosome interactions have provided antibiotics with improved pharmacologic properties and broadened spectrum of activity (including resistant strains). For these applications, attention was focused on use of antibiotics at growth-inhibitory concentrations.
It has been known for some time that antibiotics at sub-MIC have diverse physiological effects on bacteria and their eukaryotic hosts [34]; however, such activities were considered to be secondary issues in the therapeutic use of antibiotics (for example, the post-antibiotic effect [35] ) and have been largely ignored in mode-of- action studies. We have shown that subinhibitory con-
Figure 3. Use of pilvL/G-luxCDABE S. typhimurium to Identify Interactions (Synergy and Antagonism) between MLS Antibiotics and Other 50S Inhibitors
Virginiamycin, (V), telithromycin (T), erythromycin (E), sparsomycin (S), blasticidin (B), tylosin (TY), hygromycin A (H), pristinamycin IA (P1), pristinamycin IIA (P2) and pristinamycin complex (P). Top row of each panel: luminescence from each plate has been converted to the scale indicated on the right, white being high lux expression and dark blue being low lux expression. Antagonistic interactions are indicated by arrows. (I) Antagonism between (V) and (T) appears as a flattening between the (V) ring and the (T) ring. (II and III) Antagonism between (T) and (E) is shown as a flattening between the (E) ring and the (T) rings. Synergy between (V) and (E) is seen by fusing of the (E) ring with the (V) rings. (IV) Antagonism between (TY), (H), and (S) is shown by semicircular reductions of the (S) ring caused by (TY) and (H). (V) Synergy between (S) and (B) causes fusion of the two rings. (VI and VII) Synergies between (B), (S), and (E) are shown by fusions of the rings. (VIII) Synergies between (P1), (P2), (P), and (E) cause fusion of the four rings to form a leaf-shaped luminescence pattern. centrations of antimicrobials modulate global cellular acting principally with the polypeptide exit tunnel and influencing peptide egress from the ribosome. Different metabolism by fine-tuning the activity of different sets of promoters that are related to antibiotic function. The macrolides (14-, 15-, 16-membered rings) interact with other domains in the 23S rRNA that may enhance bind-fact that different antibiotics activate or repress different groups of promoters provides a novel approach to the ing. For example, telithromycin, which is active on some erythromycin-resistant strains, interacts with A2508 (do-identification of classes of antibiotics and their mode of action. Transcription modulation thus proves to be a main V) and with the loop of helix 35 of the 23S RNA [38, 39]. The MLS component lincomycin binds to the more sensitive test of small molecule activity than growth inhibition. PTC but directly inhibits peptide bond formation, whereas the streptogramins (pristinamycin) interfere Among the most valuable and widely used antibiotics are the macrolides that inhibit bacterial protein synthesis with peptide export. The transcription-modulating effects of the different by interfering with the peptide exit tunnel function on the 50S ribosome. Erythromycin is the oldest of these classes of macrolides allow fine discrimination between their structural analogs; defined panels of promoter/ compounds, and its related chemically modified derivatives dominate the therapeutic market [21, 36]. Extensive reporter fusions have utility in antibiotic discovery and identification, to assign antibiotics with unknown mode studies of macrolide binding to the 50S subunit, employing cross-linking, fingerprinting, nuclear magnetic of action to specific classes, for example. Screening can be carried out directly with crude cell supernatants resonance, and more recently high-resolution crystallographic studies, have revealed the interactions de-or extracts of producing strains in a high-throughput manner, thereby distinguishing inhibitors with novel termining the functional binding of macrolides (and other MLS antibiotics) to a small number of sites in the 23S
modes of action from known compounds at an early stage of the drug discovery process. Since the pro-rRNA. The most important interaction is with base A2508, which was first indicated from studies of MLS-moter/reporter constructs vary in their responses depending on the promoter, bacterial host, and culture resistant bacteria [11, 15, 19, 37 ]. All macrolides bind to the same site on the ribosome within the PTC, inter-medium (minimal or rich, solid or liquid), panels could 
On LB alone (I), although there is an inhibition zone around (T), only (E) induces lux expression; (A) and (T) do not induce lux expression. With cycloheximide (II) and anisomycin (III) added to the LB, (A) is upregulated compared to LB alone (I). Similarly, the response of ptsr to all three drugs (A, T, E) is increased in the presence of cycloheximide (V) and anisomycin (VI) compared to no antibiotics (IV).
be designed to discriminate between compounds on scription signatures for a variety of antibiotic classes [42] [43] [44] [45] . Using DNA bacterial arrays, these workers have the basis of mode of action or structural class. Very low concentrations of both Gram-negative and Gram-tested MIC or higher concentrations of antibiotics and found a range of transcription modulation more limited positive active compounds can be detected, even when using a Gram-negative screening host; employing hy-than what is reported here. In addition, earlier studies did not report the in-depth examination of an antibiotic persensitive hosts [40] would enhance this capability. Nonetheless, reporter libraries developed with Gram-class such as MLS. In several instances only stress responses were detected. Our studies confirm the value positive hosts such as Staphylococcus aureus would be essential to examine the full spectrum of all antibiotic of transcription modulation induced by antibiotics as a simple experimental approach to discriminating be-activities.
Comparisons of the use of promoter-lux fusions to tween structurally different inhibitors of translation. The mechanism of antibiotic-induced transcription identify functional interactions between ribosomally active antibiotics in vivo may be expedient for mode-of-modulation is not known. We suggest that antibiotics at sub-MIC bind to their known target sites on the ribosome action studies and in the screening of chemically synthesized derivatives; crude reaction products could be (albeit transiently), causing minor perturbations in ribosome function. These effects must be responsible for a tested rapidly for their activity profiles in the presence of compounds with known target specificity. 60S (eu-mechanism coupling translation to transcription, resulting in promoter-selective modulations of the latter. karyotic) ribosome inhibitors showed only weak stimulatory activity on bacterial lux reporter strains, but they
The transmission of signals from ribosome to RNA polymerase due to subinhibitory MLS could involve the re-stimulated or antagonized transcription modulation by MLS antibiotics (Figure 4 ). This suggests that compounds lease of small amounts of incomplete polypeptides [46] , interference with ribosome assembly [47] , induction of such as anisomycin and cycloheximide may interact functionally with bacterial 50S ribosomes; anisomycin translation errors [48] , or possibly interactions of small molecules with RNA [49] . The sequelae of all these is known to inhibit protein synthesis in the halobacteria. From an evolutionary standpoint, this cross-reactivity events may be low-level stress responses that act through one of the many bacterial sigma factors to acti-would be expected if the ribosomal targets for these inhibitors were conserved [41]. In any event, these ob-vate or repress specific sets of transcripts [50, 51] . These changes might also result in compensating effects on servations raise the possibility that even compounds considered as eukaryotic inhibitors could be used as the transcription of nodes of linked metabolic networks. It is clear that antibiotic inhibitors (and possibly other lead molecules in chemical modification programs to identify novel classes of antibacterial compounds active small molecules) exhibit hormesis, a phenomenon characterized by distinctly different responses at low con-on the 50S ribosome. Similar studies with a selection of antibiotics that bind to the bacterial 30S ribosome centrations (transcription modulation) compared to high concentrations (growth inhibition) [22]. We believe that subunit are in progress. We note that several groups have applied comparable approaches to obtain tran-subinhibitory concentrations identify responses that of erythromycin were placed in the middle of the plate and discs containing appropriate concentrations of other antibiotics were Experimental Procedures placed in close proximity to the central disc; tests at various displacements were necessary. In some cases, one of the antibiotics Antibiotics and Growth Conditions being tested was incorporated into the agar medium at a subinhibi-Cultures were grown aerobically in Luria-Bertani (LB) medium suptory concentration. Luminescence was monitored using the Luminoplemented with kanamycin (50 g/ml) at 37ЊC (unless otherwise graph camera; the shape of the light zone between neighboring noted). Other antibiotics were added as appropriate. Antibiotics antibiotics indicated the type of interaction (or lack thereof) between were kindly donated by industry, obtained from Sigma, or taken the two drugs. from the laboratory collection.
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